Retailer Alto Music has leaked a new portable sampler by Akai that looks inspired by the company’s MPC60 and MPC3000, according to Synth Anatomy. The streamlined $399 Akai MPC Sample will pair 16 pads ...

Nvidia's stock is up 50% from its last split in 2024. The stock has split, on average, every four years, often at a lower price than its current one. However, recent splits have only happened at much ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Liam McCabe Liam McCabe has covered HVAC since 2014. Some people stay at Hotel ...

Microsoft's inclusion in the Dow 30 adds to the pressure to split its stock. Two Dow 30 stocks have a higher nominal price than Microsoft. Nonetheless, Microsoft faces pressure in one key area that ...

Quality control in the mining industry is essential for efficient resource extraction, compliance with increasingly stringent regulations, and sound economic decision-making. It is important that ...

Kraft Heinz is pausing work on its planned split, the company announced. Many of the company's issues are "fixable and within our control," CEO Steve Cahillane said in a statement. Kraft Heinz also ...

CEO Cahillane prioritizes profitable growth To invest another $600 million across marketing, sales and R&D Kraft Heinz forecasts muted 2026 earnings; shares down 5% CEO says no end date for pause of ...

Here is a look at why companies split their stocks and why it matters. Upcoming splits worth keeping an eye on include one by Southern Copper Corp. (NYSE: SCCO). Are you ahead, or behind on retirement ...

The definition and laws for lane splitting differ by state. We have all been there, driving down the highway, sitting in traffic or stopped at a light when a motorcycle comes weaving between cars. It ...

BOE Technology has advanced its 8.6-generation OLED production line after South Korea's Sunic System passed BOE's highest-level stability assessment for its deposition equipment, prompting BOE to ...

The U.S. Food and Drug Administration (FDA) announced on Friday that it is investigating a fatality linked to Adzynma, an FDA-approved therapy developed by Takeda (TAK) for a rare blood disorder known ...

Takeda Pharmaceuticals' drug Adzynma is being investigated by the U.S. Food and Drug Administration due to a death following treatment. The FDA said Friday it has received reports of neutralizing ...